Imagine making the exact same protein found in egg whites but using microbes instead of chickens. It is like brewing a beer, but the result is a pure protein that behaves exactly like a real egg. This removes the need for farms and avoids risks like bird flu.
The global egg supply chain is fragile due to avian flu, salmonella, and cage-free mandates, leading to price instability and food insecurity.
A scalable precision fermentation process using a patented T. reesei strain to produce bioidentical ovalbumin.
If you are a bakery dealing with volatile egg prices and avian flu supply shocks — this project developed Bioalbumen that provides the same functional performance as egg protein with 87% lower CO2 emissions.
If you are a food tech company dealing with the lack of binding and foaming properties in vegan products — this project developed a bioidentical ovalbumin that offers the nutritional and functional upsides of eggs without the ethical drawbacks.
If you are a distributor dealing with the fragility of poultry supply chains and salmonella risks — this project developed a fermentation-based production process that stabilizes the food supply chain and increases food security.
The project aims to produce bioidentical egg protein with cost parity compared to traditional animal-derived eggs.
Yes, the process uses a highly scalable precision fermentation method. Onego has already achieved a key milestone with a strain producing ≥20 g/L of ovalbumin.
The production relies on a patented Trichoderma reesei fermentation-based process.
The manufacturing method results in 87% lower CO2 emissions compared to traditional animal-derived eggs.
The project period runs from 2025-01-01 to 2026-12-31, focusing on commercial and technical scale-up.
The project is led by a single Finnish SME, Onego Bio Ltd, which acts as the sole partner. This 100% industry-led structure indicates a strong drive toward commercialization rather than academic research, with the company managing both the technical strain engineering and the market regulatory work.
Contact Onego Bio Ltd in Finland for licensing or partnership inquiries.
Contact us to explore integration of bioidentical proteins into your supply chain.
